Relmada Therapeutics

RLMD

#6667

Rank

NZ$1.25 B

Marketcap

🇺🇸 United States

Country

NZ$12.00

Share price

-0.43%

Change (1 day)

989.60%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Annual Reports (10-K)

Latest form 10-K annual reports for Relmada Therapeutics CIK: 0001553643

10-K Annual Report 2026-03-19

Language: English

View Annual Report (10-K)

10-K Annual Report 2025-03-27

Language: English

View Annual Report (10-K)

10-K Annual Report 2024-03-19

Language: English

View Annual Report (10-K)

10-K Annual Report 2023-03-23

Language: English

View Annual Report (10-K)

10-K Annual Report 2022-03-25

Language: English

View Annual Report (10-K)

10-K Annual Report 2021-03-24

Language: English

View Annual Report (10-K)

10-K Annual Report 2019-09-24

Language: English

View Annual Report (10-K)

10-K Annual Report 2018-09-28

Language: English

View Annual Report (10-K)

10-K Annual Report 2017-09-28

Language: English

View Annual Report (10-K)

10-K Annual Report 2016-09-09

Language: English

View Annual Report (10-K)

10-K Annual Report 2015-09-11

Language: English

View Annual Report (10-K)

10-K Annual Report 2013-12-16

Language: English

View Annual Report (10-K)

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions